Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting
NCT06120764 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2026-05-01
Summary
The goal of this randomized controlled study is to assess the effect of guided imagery on chemotherapy-related nausea and vomiting in pediatric oncology patients.
Participants will receive either guided imagery+routine care or routine care. The researchers will compare nausea and vomiting and vital signs between groups.
Conditions
- Chemotherapy-induced Nausea and Vomiting
- Pediatric Cancer
Interventions
- OTHER
-
guided imagery
The children in the experimental group will listen to the first part of the 'Guided Imagery CD' prepared by the Turkish Psychological Association for relaxation 30 minutes before the chemotherapy infusion starts. The suggestions given in the first part of the CD will help the patients relax and focus their attention on their breathing. Patients will be positioned in a supine or semi-fowler position and will listen to the CD with headphones from a laptop. Once the chemotherapy infusion starts, relaxing light background music with the sound of a river or sea will be played based on the patients' preference, and imagery will be applied to the patients. Patients will be encouraged to think of various images, such as imagining that the treatment is over, visualizing themselves as much healthier and recovering quickly, returning to their old life, and doing whatever they want to do first after recovery. If there is an object, person, event, situation, or food that will make them feel good,
Sponsors & Collaborators
-
Hacettepe University
collaborator OTHER -
Baskent University
lead OTHER
Principal Investigators
-
Ayşe Ay, RN, PhD · Baskent University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 7 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-10
- Primary Completion
- 2026-09-30
- Completion
- 2026-10-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting
NCT01492569 ·Status: WITHDRAWN ·Phase: NA
-
Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation
NCT00716157 ·Status: COMPLETED
-
Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer
NCT00416689 ·Status: COMPLETED
-
Prevalence of Anticipatory Nausea and Vomiting in Cancer Patients Exposed to Highly Emetogenic Chemotherapy
NCT04785495 ·Status: UNKNOWN
-
Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients
NCT01442376 ·Status: COMPLETED ·Phase: PHASE3
-
Chemoradiation-Induced Nausea and Emesis: Quality of Life
NCT00394602 ·Status: TERMINATED
-
Vomiting Prevention in Children With Cancer
NCT06886451 ·Status: RECRUITING ·Phase: NA
-
Study to Evaluate Anti-emetic Effect of Aprepitant Versus Placebo in Children and Adolescent Receiving Chemotherapy
NCT01402024 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea
NCT04937309 ·Status: UNKNOWN ·Phase: NA
-
Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone
NCT05872893 ·Status: UNKNOWN ·Phase: PHASE3
-
Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)
NCT06904235 ·Status: RECRUITING ·Phase: PHASE2
-
Prevalence of Delayed Chemotherapy Associated Nausea
NCT04342780 ·Status: COMPLETED
-
Evaluation of the Efficacy and Safety of Megestrol Acetate in Preventing Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy
NCT07130617 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
NCT07169851 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy of Aprepitant (Emend®) in Children
NCT01661335 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis (0000-041)
NCT00211601 ·Status: COMPLETED ·Phase: NA
-
Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy
NCT07217600 ·Status: RECRUITING ·Phase: PHASE4
-
Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer
NCT06200168 ·Status: RECRUITING ·Phase: PHASE3
-
Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children
NCT06208917 ·Status: RECRUITING ·Phase: PHASE3
-
Nano-crystalline Megestrol Acetate for Chemotherapy-induced Nausea and Vomiting
NCT07246070 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Predict CHimio-or Radiation-induced NAusea and Vomiting in Children/adolescents Treated for Cancer
NCT06869005 ·Status: NOT_YET_RECRUITING
-
Psychometric Properties of the Chinese Version of PeNAT
NCT04827108 ·Status: UNKNOWN
-
Prevention of Unmitigated Chemotherapy-induced Emesis
NCT03996863 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy and Safety of Fosaprepitant in Preventing Chemotherapy-induced Vomiting in Children Treated With Medium and High Emetic Chemotherapeutic Drugs
NCT05230654 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Predictive Risk Factors of Chemotherapy-induced Nausea and Vomiting
NCT01993381 ·Status: UNKNOWN